Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder

Journal of Psychiatric Research

Volumn 47, Issue 3, 2013, Pages 307-314

  Medina, Adriana ^a   Seasholtz, Audrey F ^a   Sharma, Vikram ^a   Burke, Sharon ^a   Bunney, William ^b   Myers, Richard M ^c   Schatzberg, Alan ^d   Akil, Huda ^a   Watson, Stanley J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Glucocorticoid receptor; Hippocampus; HPA axis; In situ hybridization; Major depressive disorder; Mineralocorticoid receptor

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BUSPIRONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; LORAZEPAM; MINERALOCORTICOID RECEPTOR; PAROXETINE; SERTRALINE; ZOLPIDEM TARTRATE;

ADULT; AFFECT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EMOTION; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; SUICIDE;

EID: 84873524329     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.11.002     Document Type: Article

References (47)

1. Akil H., Haskett R.F., Young E.A., et al. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin. Biological Psychiatry 1993, 33(2):73-85.
2. Alt S.R., Turner J.D., Klok M.D., et al. Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 2010, 35(4):544-556.
3. Banasr M., Soumier A., Hery M., et al. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biological Psychiatry 2006, 59(11):1087-1096.
4. Bannerman D.M., Yee B.K., Good M.A., et al. Double dissociation of function within the hippocampus:a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behavioral Neuroscience 1999, 113(6):1170-1188.
5. Bannerman D.M., Rawlins J.N., McHugh S.B., et al. Regional dissociations within the hippocampusememory and anxiety. Neuroscience & Biobehavioral Reviews 2004, 28(3):273-283.
6. Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. Journal of Neuroendocrinology 1989, 1(6):485-488.
7. Checkley S. The neuroendocrinology of depression and chronic stress. British Medical Bulletin 1996, 52(3):597-617.
8. Colombo M., Fernandez T., Nakamura K., et al. Functional differentiation along the anterior-posterior axis of the hippocampus in monkeys. Journal of Neurophysiology 1998, 80(2):1002-1005.
9. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. Journal of Comparative Neurology 1993, 332(1):1-20.
10. De Kloet E.R., Vreugdenhil E., Oitzl M.S., et al. Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 1998, 19(3):269-301.
11. Dolorfo C.L., Amaral D.G. Entorhinal cortex of the rat: organization of intrinsic connections. Journal of Comparative Neurology 1998, 398(1):49-82.
12. Dong H.W., Swanson L.W., Chen L., et al. Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(28):11794-11799.
13. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65(1):7-19.
14. Gesing A., Bilang-Bleuel A., Droste S.K., et al. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. Journal of Neuroscience 2001, 21(13):4822-4829.
15. Halbreich U., Asnis G.M., Shindledecker R., et al. Cortisol secretion in endogenous depression. I. Basal plasma levels. Archives of General Psychiatry 1985, 42(9):904-908.
16. Herman J.P., Cullinan W.E., et al. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Research 1992, 592(1-2):228-238.
17. Herman J.P., Cullinan W.E., Morano M.I., et al. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. Journal of Neuroendocrinology 1995, 7(6):475-482.
18. Jayatissa M.N., Bisgaard C., Tingström A., et al. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31(11):2395-2404.
19. Juruena M.F., Pariante C.M., Papadopoulos A.S., et al. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. British Journal of Psychiatry 2009, 194(4):342-349.
20. Kabbaj M., Devine D.P., Savage V.R., et al. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. Journal of Neuroscience 2000, 20(18):6983-6988.
21. de Kloet E.R., Rots N.Y., van den Berg D.T., et al. Brain mineralocorticoid receptor function. Annals of the New York Academy of Sciences 1994, 746:8-20. discussion 20-21, 64-27.
22. Klok M.D., Alt S.R., Irurzun Lafitte A.J., et al. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. Journal of Psychiatric Research 2011, 45(7):871-878.
23. Klok M.D., Giltay E.J., Van der Does A.J., et al. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Translational Psychiatry 2011, 1:e62.
24. Lembke A., Gomez R., Tenakoon L., et al. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology 2012.
25. Leonardo E.D., Richardson-Jones J.W., Sibille E., et al. Molecular heterogeneity along the dorsal-ventral axis of the murine hippocampal CA1 field: a microarray analysis of gene expression. Neuroscience 2006, 137(1):177-186.
26. Li J.Z., Vawter M.P., Walsh D.M., et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Human Molecular Genetics 2004, 13(6):609-616.
27. Lopez J.F., Chalmers D.T., Little K.Y., et al. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry 1998, 43(8):547-573.
28. Atlas of the human brain 2008, Elsevier Inc, New York, NY. J.K.P. Mai, George, T. Voss (Eds.).
29. Meaney M.J., Szyf M., Seckl J.R. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends in Molecular Medicine 2007, 13(7):269-277.
30. Moser M.B., Moser E.I. Functional differentiation in the hippocampus. Hippocampus 1998, 8(6):608-619.
31. Otte C., Hinkelmann K., Moritz S., et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. Journal of Psychiatric Research 2010, 44(6):339-346.
32. Pitkanen A., Pikkarainen M., Nurminen N., et al. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Annals of the New York Academy of Sciences 2000, 911:369-391.
33. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117(6):2505-2511.
34. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nature Neuroscience 2007, 10(9):1110-1115.
35. Seckl J.R., Dickson K.L., Yates C., et al. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Research 1991, 561(2):332-337.
36. Strange B.A., Fletcher P.C., Henson R.N., et al. Segregating the functions of human hippocampus. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(7):4034-4039.
37. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. Journal of Comparative Neurology 1977, 172(1):49-84.
38. Thompson C.L., Pathak S.D., Jeromin A., et al. Genomic anatomy of the hippocampus. Neuron 2008, 60(6):1010-1021.
39. Trapp T., Rupprecht R., Castrén M., et al. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 1994, 13(6):1457-1462.
40. Vawter M.P., Shannon Weickert C., Ferran E., et al. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochemical Research 2004, 29(6):1245-1255.
41. Viard A., Doeller C.F., Hartley T., et al. Anterior hippocampus and goal-directed spatial decision making. Journal of Neuroscience 2011, 31(12):4613-4621.
42. Wang S.S., Kamphuis W., Huitinga I., et al. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Molecular Psychiatry 2008, 13(8). 786-799, 741.
43. Wang Q., Joels M., Swaab D.F., et al. Hippocampal GR expression is increased in elderly depressed females. Neuropharmacology 2012, 62(1):527-533.
44. Watzka M., Beyenburg S., Blümcke I., et al. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neuroscience Letters 2000, 290(2):121-124.
45. Webster M.J., Knable M.B., O'Grady J., et al. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry 2002, 7(9). 985-994, 924.
46. Young E.A., Lopez J.F., Murphy-Weinberg V., et al. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. Journal of Clinical Endocrinology & Metabolism 1998, 83(9):3339-3345.
47. Young E.A., Lopez J.F., Murphy-Weinberg V., et al. Mineralocorticoid receptor function in major depression. Archives of General Psychiatry 2003, 60(1):24-28.